Loading clinical trials...
Loading clinical trials...
Researchers want to learn if calderasib given alone or with cetuximab can treat certain advanced solid tumors in people with the KRAS G12C mutation. The goals of this study are to learn: * How many ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Merck Sharp & Dohme LLC
NCT06310330 · Breast Neoplasm Malignant Primary
NCT06606366 · Neoplasm Malignant
NCT05247268 · Endometrial Neoplasm Malignant Stage I
NCT05941299 · Mastectomy, Segmental, Breast Neoplasm Malignant Female
NCT04973293 · Lung Neoplasm Malignant
Greater Baltimore Medical Center ( Site 1104)
Baltimore, Maryland
START Midwest ( Site 1103)
Grand Rapids, Michigan
Rutgers Cancer Institute of New Jersey ( Site 1100)
New Brunswick, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions